Comparing ICD shock ratios between Type 1, Type 2 and non diabetic patients
Open Access
- 8 May 2023
- journal article
- research article
- Published by Lycia Press London UK in Medical Science and Discovery
- Vol. 10 (5) , 275-284
Abstract
Objective: The use of permanent pacemakers and implantable cardioverter defibrillators (ICDs) is increasing. With technological advances, the devices' implantation techniques and programmable features are improving, and indications are expanding. Several technical and clinical problems are encountered during implantation and follow-up of these devices. Methods: Our study retrospectively evaluated diabetic and non-diabetic patients who underwent ICD implantation in Mersin University Cardiology Department between January 2010 and December 2013 according to current indications. All clinical characteristics, baseline, 1-month and 6-month follow-up pacemaker data and baseline laboratory values were recorded. Results: A total of 106 ICD patients (57 diabetics and 49 nondiabetics) were enrolled at the 1st and 6th months of follow-up. 47.2% of the patients were male and the mean age was 56±7.3 years. ICDs were implanted for secondary prevention in 83.9% of patients. ICD was implanted for coronary artery disease +/- ventricular tachycardia (VT) or ventricular fibrillation (VF)+/- synchronization disorder. 75.4% of patients had CAD, and 89.6% had heart failure. The mean ejection fraction ratio (EF) was 31.3%. Early complications were observed in 10.3% of patients. 47.1% of patients received any treatment by the ICD, 34.9% had the appropriate shock, and 12.2% had inappropriate shock. The complication rate was 10.3%. While there was no difference in ventricular impedance and threshold values in diabetic patients compared to the control group, ventricular lead R amplitude values were found to be higher. The rate of atrial fibrillation was significantly different in the treated group. Treatment response was obtained in 71.4% of patients who underwent treatment change due to appropriate shock, incorrect shock and ATP. Conclusion: In conclusion, the incidence of appropriate shock and anti-tachycardic pacing was higher in diabetic patients than non-diabetic patients.Keywords
This publication has 17 references indexed in Scilit:
- Comparison of β-Blockers, Amiodarone Plus β-Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter DefibrillatorsThe OPTIC Study: A Randomized TrialJAMA, 2006
- What is the “Optimal” follow-up schedule for ICD patients?EP Europace, 2005
- Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trialEuropean Heart Journal, 2004
- Assessment and therapy of selected endocrine disordersAnesthesiology Clinics of North America, 2004
- Efficacy of Implantable Cardioverter Defibrillator Therapy for Primary and Secondary Prevention of Sudden Cardiac Death in Hypertrophic CardiomyopathyPacing and Clinical Electrophysiology, 2003
- Consensus Statement on Indications, Guidelines for Use, and Recommendations for Follow‐up of Implantable Cardioverter DefibrillatorsPacing and Clinical Electrophysiology, 2001
- Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 casesAmerican Heart Journal, 1989
- Prognostic factors in nonsustained ventricular tachycardiaThe American Journal of Cardiology, 1984
- Termination of Malignant Ventricular Arrhythmias with an Implanted Automatic Defibrillator in Human BeingsNew England Journal of Medicine, 1980
- Resuscitation of the Heart in Ventricular Standstill by External Electric StimulationNew England Journal of Medicine, 1952